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Abstract
This paper summarises key advances and priorities since the 2011 presentation of the
Malaria Eradication Research Agenda (malERA), with a focus on the combinations of inter-
vention tools and strategies for elimination and their evaluation using modelling approaches.
With an increasing number of countries embarking on malaria elimination programmes,
national and local decisions to select combinations of tools and deployment strategies
directed at malaria elimination must address rapidly changing transmission patterns across
diverse geographic areas. However, not all of these approaches can be systematically eval-
uated in the field. Thus, there is potential for modelling to investigate appropriate ‘packages’
of combined interventions that include various forms of vector control, case management,
surveillance, and population-based approaches for different settings, particularly at lower
transmission levels. Modelling can help prioritise which intervention packages should be
tested in field studies, suggest which intervention package should be used at a particular
level or stratum of transmission intensity, estimate the risk of resurgence when scaling down
specific interventions after local transmission is interrupted, and evaluate the risk and impact
of parasite drug resistance and vector insecticide resistance. However, modelling interven-
tion package deployment against a heterogeneous transmission background is a challenge.
Further validation of malaria models should be pursued through an iterative process,
whereby field data collected with the deployment of intervention packages is used to refine
models and make them progressively more relevant for assessing and predicting elimination
outcomes.
Summary points
• Since 2011, there have been significant improvements in the development, organisation,
and infrastructure of country programmes for malaria control and elimination globally.
This has included the increasing use of combinations of interventions against the mos-
quito vector and the parasite in humans to reduce transmission in large and expanding
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geographies and populations and an adaptation of these interventions as transmission is
progressively reduced.
• Similarly, there has been substantial improvement in the sophistication and field valida-
tion of malaria transmission models and their ability to describe and predict the effects
of ecologic changes and the impact of specific interventions. These advances permit the
investigation and comparison of multiple complementary interventions in elimination
settings.
• There is an increasing need to combine interventions into ‘packages’ that can be tailored
to specific settings based on the characteristics of their transmission dynamics and epi-
demiology (landscape stratification). The challenge is to identify the complementary
components of each intervention package and establish the triggers and thresholds for
their deployment (or withdrawal) throughout the elimination process, including main-
taining elimination once transmission has been interrupted.
Introduction
In 2011, the Malaria Elimination Research Agenda (malERA) made recommendations for
how mathematical modelling efforts could best inform policy and guide research for specific
intervention tools for elimination—diagnostics, drugs, vector control, and vaccines [1]. Since
then, experience with malaria intervention tools has grown, and the toolbox has expanded
with new drugs, new insecticides, better diagnostics, and a first vaccine [2]. As more countries
seek elimination, grouping tools to best address diverse and changing transmission intensity
has become a central issue. Some tools are oriented primarily towards reducing disease bur-
den, e.g., seasonal malaria chemoprevention; others are dedicated to reducing transmission,
e.g., drug-based population-wide parasite clearance; and some meet both of these objectives,
e.g., vector control. Thus, not all tools will contribute equally to malaria elimination, and the
timing and duration of their use must adapt as programmes progress.
This paper summarises progress since the initial malERA publication regarding transmis-
sion-aligned ‘elimination tool packages’ and deployment strategies and opportunities for mod-
els to help inform and prioritise intervention choices. The findings come from an extensive
literature review of published and unpublished materials and the deliberations of the 2015
malERA Refresh Consultative Panel on Combination Interventions and Modelling, which
includes specialists from malaria modelling, field researchers, and National Malarial Control
Programme (NMCP) representatives [3].
Methods
The findings presented in this paper result from an extensive literature review of published
and unpublished materials and the deliberations of the 2015 malERA Refresh Consultative
Panel on Combination Interventions and Modelling. Electronic databases were systematically
searched for published literature from 1 January 2010 until 1 August 2015, without language
limitations. The websites of the institutions that apply modelling techniques to malaria
research questions and the MESA Track database of current research projects relevant to
malaria elimination were systematically searched to identify pertinent ongoing research.
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Panellists were invited to recommend additional literature and additional ongoing research
projects. The comprehensive search for literature and ongoing research provided the basis for
launching the second step.
A 2-day workshop was held with the majority of the panel members, including specialists
from malaria modelling, field researchers, and NMCP representatives. The panel broke into 2
working groups to identify the issues in combining interventions and how mathematical
modelling could be applied to these problems. Each group fed back to a plenary session in
which further robust discussions and input occurred. This helped refine the opportunities and
gap areas in which research is needed. The final findings were arrived at with inputs from all
panellists and several iterations of the manuscript.
Intervention packages to achieve elimination
Over the past 5 years, regardless of initial local transmission levels, most countries have contin-
ued to reduce the clinical burden of malaria and transmission [4]. The World Health Organi-
zation (WHO) recently published its Global Technical Strategy (GTS) for Malaria 2016–2030
(Fig 1) [5]. This builds on the core activities of vector control, case management, and surveil-
lance, with additional interventions to accelerate progress to elimination. In the GTS, for the
first time, modelling studies were used to support goal setting [5].
The malERA Refresh Consultative Panel on Combination Interventions and Modelling
approach encompassed the full spectrum of malaria transmission—addressing emerging pro-
grammatic aims and combining into ‘packages’ the available tools and strategies directed
towards malaria elimination (Fig 2). As transmission is reduced to very low levels, the inter-
vention packages must adapt to increasingly focal and heterogeneous populations, in which
infections are rare. Given the extensive range of available tools and the diversity/heterogeneity
of transmission settings, it becomes difficult to field test all possible intervention packages.
Models can assist the prioritisation and design of clinical trials and in the choice of an inter-
vention package to achieve their desired goals.
Progress in combination interventions and modelling
Initial malERA recommendations for a research and development agenda in mathematical
modelling are shown in Box 1 [1]. Subsequently, the scope and depth of research has expanded
to include diverse vector control strategies, complex diagnostics, drug and vaccine dynamics,
and deployment strategies. Additionally, infection models have advanced following incorpo-
ration of new field trial data, particularly regarding mass drug administration (MDA) and spe-
cific aspects of vector control, providing greater plausibility to model predictions.
The interface between modelling and implementation has not developed as was perhaps
envisaged, in terms of appropriate portals to allow ’end users’ access to relevant software and
explore the effect of varying conditions on the ideal choice of control measures. However, the
development, organisation, and infrastructure of malaria modelling has improved (Box 2),
and recent efforts include an expansion of open-access data and software [6–13]. Also, model-
ling has been incorporated at the policy level within WHO [5] and included in planning tools
for malaria elimination [14]. Wider implementation is possibly now dependent upon the
development of next-generation models that sufficiently address combination interventions
against a background of heterogeneity and low transmission as more countries move towards
elimination.
These advances are complemented by discoveries in basic science, large field trials of new
and existing interventions, and substantial data gathering efforts that provide the raw evidence
to further validate models. A number of recent reports used models to address the role of
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multiple complementary interventions (Table 1) [15–35], and additional field trials are ongo-
ing (Table 2) [29].
Consensus modelling
In consensus modelling, independent modelling groups examine the same research question,
sometimes using the same source dataset to parameterise their model. Through objective com-
parison and critique, modelling groups have reached a degree of consensus on important
issues, such as the relationship between health burden and transmission intensity [6], and have
undertaken an in-depth analysis for the RTS,S vaccine [36]. Such efforts are resource intensive
but may give robust answers incorporating the breadth of uncertainty in our understanding.
There is also value in less intensive forms of model comparison in which common findings
from work conducted independently are assessed (Table 3) [9,18,21,23,24,28,30–32,35,37–58].
This approach can also be particularly useful for identifying areas in which there is a lack of
consensus, as this can focus efforts on further model development, basic science, and field data
collection needs.
Fig 1. Schematic of the pillars and supporting elements of the World Health Organization (WHO) Global Technical Strategy for
Malaria 2016–2030 (source: WHO, 2015) [5].
https://doi.org/10.1371/journal.pmed.1002453.g001
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Fig 2. An example of the role of modelling across the spectrum of malaria elimination. Note that the measures of transmission are based on
sub-Saharan Africa, and other constructs and transmission levels may be relevant in different geographical areas. Malaria transmission intensity
measures and the relationship entomologic inoculation rate for Plasmodium falciparum from very high to zero transmission are adapted from data
presented in [6]; personal communication from D. Smith and P. Gething. Zero refers to no locally transmitted cases of malaria infection; imported
infections may be identified. Intervention package components and sequencing will depend on transmission intensity at the start of the elimination
programme, the speed at which transmission declines, and the underlying typology (i.e., malaria epidemiology, species, vector ecology, and health
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Next steps for combination interventions and modelling in malaria
elimination
Fig 2 provides an example of how transmission strata, programmatic aims, the choices of interven-
tion packages, and the iterative development between modelling and programme choices change
together as malaria transmission intensity is progressively reduced towards zero, summarizing key
opportunities and identifying challenges. Note that not all countries will start from high transmis-
sion levels and that the measures of transmission used in Fig 2 are based on sub-Saharan Africa.
Thus, other constructs and transmission levels may be relevant in different geographical areas.
Opportunities
Combination intervention modelling
There has been considerable progress in modelling combination interventions. Models have
been developed to examine the overall expected impact of diagnostic, drug, vaccine, and vector
system factors). EIR, entomologic inoculation rate: average number of infectious mosquito bites per person per year; N.B. the table is organised by
log differences in the EIR, and other measures are aligned (approximated) based on these entomologic measures. PfPR, P. falciparum parasite
rate: proportion of people with a current infection with P. falciparum—typically determined by a population-based survey and often timed to a
specific interval of the transmission season. API, annual parasite index: number of confirmed malaria cases per 1,000 population per year. Cases,
cases per health facility per week: average number of confirmed malaria cases expected to present on an average week to a health facility serving a
population of 5,000 people. Because many infections can be asymptomatic at any point in time (and thus not present to health services), the
proportion of asymptomatic individuals varies with transmission intensity, and because most transmission is seasonal, these average estimates
may vary substantially by location and season.
https://doi.org/10.1371/journal.pmed.1002453.g002
Box 1. 2011 malERA research agenda for modelling to support
malaria elimination.
Further development of models and model systems:
• Within-host dynamics of Plasmodium infections
• The human infectious reservoir
• Bionomics and ecology of the vectors
• Dynamics of the stimulation and decay of human immunity across a range of trans-
mission settings
• Heterogeneities in host, vector, and parasite dynamics
• Heterogeneities in host and vector movements
• Drug pharmacokinetics/pharmacodynamics
• Vaccines that interrupt malaria transmission
• Ecology of genetically modified mosquitoes
• Development and impact of drug and pesticide resistance
• Integration of health system attributes and linking to microeconomic outputs
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control intervention combinations, including cost-effectiveness [16,18–20,24,48,57,59–62],
and comparing interventions added to the backbone of standard measures [21–23,25–
27,30,36,63,64]. Modelling studies have investigated the applications of several new potential
interventions such as the RTS,S vaccine [36], ivermectin [19,54], mosquito traps [17], and
next-generation diagnostics [25,33,65,66] and have highlighted critical attributes of new prod-
ucts, such as a preerythrocytic vaccine [20,67–69], genetically modified mosquitos [70–72],
and combinations of future interventions [73].
Models are designed to allow scale-up and scale-down of interventions over time. The next
step is to define the epidemiological information that would be most informative for making
such dynamic changes and the triggers for switching or scaling. The aim is to develop a set of
rules that define the characteristics of transmission that can direct specific changes in the compo-
sition and phasing of intervention packages and their targeting to specific locations and popula-
tions. These predictions can then be evaluated with further evidence from specific field trials. If
reliable, such measures could be used in the subnational stratification of intervention packages.
Accelerating community clearance of malaria parasites. One hypothesis being tested in
various settings is the potential to accelerate elimination by targeting the human parasite reser-
voir (symptomatic and asymptomatic) with time-limited deployment of community-based
interventions such as MDA or mass screening and treatment (MSAT) [74]. If the intervention
is justified, a wealth of modelling studies provides guidance on optimizing its deployment
Box 2. Recent advances in malaria modelling.
Communications:
• A growing number of modelling groups are working in a collaborative fashion
• Greater engagement between modellers, country programmes, and operational
research partners has helped refine the paramount research questions
Models:
• The development of model systems that are diverse but much improved in terms of
their incorporation of malaria biology and natural history, as well as validated esti-
mates for intervention effects, drug pharmacokinetics/ pharmacodynamics, and vac-
cine dynamics
• The development of models that allow the investigation of target product profiles for
new tools—for example, diagnostics, surveillance systems, and drugs
Infrastructure:
• Greater dissemination of malaria models at different levels of user-interface complex-
ity, through online hosting and open-source code repositories leading to wider access
to modelling information for programme implementers, planners, and policy decision
makers
• Improved means of compiling data and using common ontologies, frameworks, and
metadata standards with growing international databases of some measures of malaria
transmission, e.g., parasite rate surveys
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[15,18,28,32,33,41,53–55,57,75–79]. However, estimating the level of coverage required for
successful MDA is critical [53], and for MSAT, the sensitivity of the diagnostic tool is an addi-
tional key determinant of efficacy as the current tests may fail to detect low-level infections
[16,25].
Current models of MDA all include the parameters whereby immediately following MDA,
there is a dramatic drop in malaria prevalence, but in the absence of elimination, prevalence
returns to preintervention levels (albeit at different rates depending on the model) [53]. Coun-
try malaria programs are increasingly aware of this potential and have learned not to rely solely
on MDA to eliminate transmission; thus, MDA is an accelerator used to move to a next set of
interventions and strategies to find and clear the remaining transmission foci. The models
must now be adapted to include a next set of actions with the potential to end transmission,
i.e., MDA moving to focal MDA (fMDA) and other reactive strategies in households and
neighbourhoods with rare but remaining transmission [33,79,80]. In the field, these increas-
ingly infrequent actions will require robust local information systems as part of the interven-
tion, rather than models.
Non-falciparum species. Recent progress has been made in models considering non-fal-
ciparum parasites and vectors, though further work is needed [76,81–95]. To address the public
health and public engagement challenge of eliminating all human malaria species, multispecies
Table 1. Key modelling studies on combination interventions quarter 4 2010–quarter 1 2016, with the
main outcome indicated.
Multi-intervention combined
• Mass campaigns with antimalarial drugs are highly effective at interrupting transmission if deployed shortly
after ITN campaigns [15].
• Compared with untargeted approaches, selective targeting of hot spots with drug campaigns is an
ineffective tool for elimination because of limited sensitivity of available field diagnostics [16].
• High coverage with a combination of LLINs and attractive toxic sugar baits could result in substantial
reductions in malaria transmission [17].
• Mass treatment needs to be repeated or combined with other interventions for long-term impact in many
endemic settings [18].
• Including ivermectin in mass treatment strategies could be a useful adjunct to reduce and interrupt malaria
transmission [19].
• Preerythrocytic vaccines will have a maximum impact where bed net coverage has saturated, vector
feeding is primarily outdoors, and transmission is moderate to low [20].
Multi-intervention compared
• While adult killing methods can be highly effective under many circumstances, other vector control
methods are frequently required to fill effective coverage gaps [21].
• Adding vaccines to existing vector control efforts extends the ability to achieve elimination starting from
higher baseline transmission levels and with less favourable vector behaviour [22].
• Decreases in malaria transmission and burden can be accelerated over the next 15 years if the coverage
of key interventions is increased [23].
• Vector control plans should consider the spatial arrangement of any intervention package to ensure
effectiveness is maximised [24].
• The sensitivity of the diagnostic can play a part in increasing the chance of interrupting transmission [25].
• A failing partner drug will result in greater increases in malaria cases and morbidity than would be
observed from artemisinin resistance only [26].
• Selecting combinations of interventions that target different stages in the vector’s life cycle will result in
maximum reductions in mosquito density [27]
Multi-intervention: Cost-effectiveness
• In all the transmission settings considered, achieving a minimal level of ITN coverage is a ‘best buy’. At
low transmission, MSAT probably is not worth considering. Instead, MSAT may be suitable at medium to
high levels of transmission and at moderate ITN coverage [28].
ITN, insecticide-treated bed net; LLIN, long-lasting insecticidal bed net; MSAT, mass screening and
treatment.
https://doi.org/10.1371/journal.pmed.1002453.t001
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mathematical models that consider unified strategies and exploit the interactions between the
species for improved cost-effectiveness should be used [96]. Notably, where P. vivax is present,
the malaria programme might be sustained even as P. falciparum becomes rare and is elimi-
nated. However, different approaches to both surveillance and malaria interventions would be
required to reduce the P. vivax burden while detecting P. falciparum cases and preventing the
reestablishment of P. falciparum transmission.
Surveillance as an intervention
Surveillance is an intervention tool. When honed for elimination purposes, surveillance must
evolve to be able to discover evidence of transmission; establish its location, timing, nature,
Table 2. Ongoing field studies in combination interventions as reported on the MESA Track database
[29].
Vector control
• Combining indoor residual spraying and long-lasting insecticidal nets for malaria prevention: a cluster
randomised controlled trial in Ethiopia (Maltrials); Ethiopia (Sep 2014–Sep 2016); Addis Ababa University,
Ethiopia
• Integrated vector management: Interaction of larval control and indoor residual spraying on Anopheles
gambiae density and vectorial capacity for human malaria; Malaria Research and Training Center (MRTC),
University of Bamako, Mali
• IRS and LLIN: Integration of methods and insecticide mode of actions for control of African malaria
vector mosquitoes; Tanzania, United Republic of; Ifakara Health Institute (IHI), Swiss Tropical and Public
Health Institute (Swiss TPH)
• Cluster randomised trial of the impact of dual-insecticide treated nets vs. traditional LLINs on malaria
vectors and malaria epidemiology in 2 districts of Mali; Mali (Dec 2013–Dec 2014); Centers for Disease
Control and Prevention (CDC), United States
• The Majete Integrated Malaria Control Project (MMP): Community-based malaria control in the
perimeter of Majete Wildlife Reserve in Chikhwawa district using a Scale-Up-For-Impact (SUFI) strategy,
assessing complementary intervention options, including larval source management and house
improvement; Malawi (Jan 2014–Dec 2018); Wageningen University, Netherlands; University of
Amsterdam; College of medicine, University of Malawi; Liverpool School of Tropical Medicine
Case management and surveillance
• Routine case investigation and reactive case detection for malaria elimination in Richard-Toll District in
northern Senegal; Senegal (2012–2017); PATH MACEPA, National Malaria Control Programme (NMCP)
Senegal
Mass treatment
• The Haiti Malaria Elimination Consortium (HaMEC); Dominican Republic, Haiti (Feb 2015–2020);
Malaria Zero Consortium, US
• Assessing the effectiveness of household-level focal mass drug administration and community-wide
mass drug administration with dihydroartemisinin + piperaquine for reducing malaria parasite infection
prevalence and incidence in Southern Province Zambia; Zambia (2014–2016); PATH MACEPA, Tulane
University, Zambian National Malaria Control Centre
• Population parasite clearance to decrease malaria transmission in Amhara Region, Ethiopia: a pilot
study; Ethiopia (2014–2015); PATH MACEPA, Ministry of Health (MOH) Ethiopia
• Reduction of malaria parasitaemia and transmission in low to moderate seasonal transmission settings
(Kanel, Rane´rou and Linguère) in Senegal: a pilot study; Senegal (2014–2015); PATH MACEPA, National
Malaria Control Programme (NMCP) Senegal
• Community reactive case detection versus reactive drug administration in malaria elimination areas: a
cluster randomised controlled trial; Zambia (2016–Dec 2017); Akros
• Assess the micro-epidemiology of resistant falciparum malaria in SE Asia and to perform and evaluate
an intervention with targeted chemo-elimination through a modified mass drug administration approach
(Cambodia, Myanmar, Thailand, Vietnam); Cambodia, Myanmar, Thailand, Vietnam (2014–Oct 2016);
Mahidol Oxford Tropical Medicine Research Unit (MORU)
• Evaluation of the impact of seasonal malaria chemoprevention delivered by district health services in
southern Senegal; Senegal (2013–2018); Cheikh Anta Diop University, Senegal
IRS, indoor residual spraying; LLIN, long-lasting insecticidal net; SE, Southeast.
https://doi.org/10.1371/journal.pmed.1002453.t002
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and causes; identify and eliminate residual foci; prevent, detect, and contain imported malaria;
and demonstrate the attainment and maintenance of zero malaria transmission [97]. As trans-
mission declines, modification of data collection and reporting systems requires substantial
investment and coordination across the malaria programmes and the surveillance manage-
ment unit. Designing the necessary flexibility into a surveillance system to allow for adaptation
to an elimination context will be critical.
There is an opportunity to use modelling to define the required components of surveillance
systems depending on the stage of the elimination programme. This requires quantification of
the detrimental effects of inaccurate, insufficient, or untimely surveillance and the beneficial
effects of adding new measures to the surveillance system [25]. Modelling could also be used to
Table 3. Consensus across multiple groups from modelling analyses conducted by each of the
Malaria Modelling Consortiuma groups, which assessed impact on malaria transmission of combin-
ing multiple interventions or multiple methods of using a single interventionb.
Vector control
• Achieving and maintaining high effective coverage of the population with LLINs is consistently predicted to
result in the greatest reduction in transmission in a variety of settings and in many cases enables other
interventions to become more effective and longer lasting [21,23,24,28,30,32,35,37–43,55].
• Other interventions such as IRS are also predicted to be effective and can even be more effective than
LLINs in specific settings, particularly if sustained and optimised through seasonal or spatial targeting
strategies [32,39,42].
• Vector control interventions that maximise killing of adult female mosquitoes are predicted to have the
greatest transmission reducing effect (as opposed to repellents or killing juveniles); however, the optimal
choice of intervention(s) will depend on both the specific bionomics of local vectors and the costs required
to reach high levels of effective coverage with each intervention [21,23,44–46].
Case management and surveillance
• Even before considering elimination, improving access to care has an important role to play in significantly
reducing deaths and severe disease [9,41,47–49].
• While differing considerably in magnitude, all the models agree that levels of access to treatment of
incident malaria cases and the delay in seeking treatment are 2 key measures that influence the endemicity
at baseline (no interventions) and, as such, determine the following:
 what scale of community-based programme will be required to achieve and maintain elimination
[28,30,32]
 what the risk will be of scaling back vector-based interventions post elimination [23,43,50,51]
Mass Treatment
• Short mass treatment campaigns will reduce the parasite reservoir—and consequently, transmission—in
the short term but will have no long-term benefits unless other interventions are scaled up at the same time
and then maintained [18,23,28,31,32,35,42,52–55].
• Treating a large proportion of the population in a single year in at least 1 round is a key determinant of
MDA effectiveness whether it is achieved through high coverage in a single round or through follow-up
rounds that reach new individuals [41,53,55–57]
• The addition of primaquine to MDA with long-lasting ACTs offers a small additional transmission reduction
in the majority of epidemiological settings [18,30–32,42,53,54,57,58].
• Due to the prophylactic effect of treatment, MDA will always be more effective than MSAT or fMDA. If
adherence or drug resistance is included in the model analysis, then this conclusion is more nuanced, and
risk of drug resistance emergence and spread is an area with a lack of clear consensus among existing
models [18,31,35,41].
• The longer-term effectiveness of MDA is highly sensitive to the population size of the trial area and its
connectedness to other areas [18].
a Imperial College, London, United Kingdom; Institute for Disease Modelling, Seattle, Washington, US;
Mahidol Oxford Tropical Medicine Research Unit, Bangkok, Thailand; Swiss Tropical and Public Health
Institute, Basel, Switzerland; and University of Oxford, Oxford, UK.
b Compiled by Oliver Brady (University of Oxford) and Samantha Galvin (Bill & Melinda Gates Foundation).
ACT, artemisinin-based combination therapy; fMDA, focal mass drug administration; IRS, indoor residual
spraying; LLIN, long-lasting insecticidal bed net; MDA, mass drug administration; MSAT, mass screening
and treatment.
https://doi.org/10.1371/journal.pmed.1002453.t003
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assess the level of hidden/unidentifiable cases/infections that would hinder (or would not hin-
der) elimination (e.g., asymptomatic or individuals with minor symptomology who would not
seek treatment). As transmission declines, the addition of serological measures of past expo-
sure [65,98–102] or active community-based transmission measurements and reactive case
management [103–107] may be considered. Modelling can estimate the incremental benefit of
adding specific surveillance activities to an already established surveillance system and could
examine cost-effectiveness issues [48,108], specific epidemiologic aspects of contract tracing
[109], and the target product profile of diagnostics [25,65,66] in case-investigation or foci-
investigation settings.
Parasite and vector resistance
As efforts to reduce transmission are intensified, the risk and impact of parasite drug resistance
and vector insecticide resistance becomes a key concern [110–112]. Modelling has been used
to investigate the effects of resistance [25,26,30,32,113–116], and there have been some studies
examining risk factors for resistance and drug failure [114,117–119]. Geostatistical models are
also being developed to predict localities where resistance might be present in order to target
surveillance activities, for example, mapping artemisinin-resistance in Southeast Asia [120].
The biology and natural history of mosquito vectors and malaria parasites tells us that the
development and evolution of resistance will continue, given the pressure of insecticides and
drugs. In terms of drug treatments, with artemisinin-based combination therapies (ACTs)
globally recommended for malaria treatment, the focus must be on investigation of artemisi-
nin and partner drug resistance, in terms of how this can be contained within the Greater
Mekong subregion [111], and how its emergence or importation can be avoided in other
regions [25,115]. Note that as transmission declines, the remaining parasites are those most
likely to harbour resistance. Thus, even as malaria cases decline, continued field studies and
modelling must be supported to address the efficacy and effectiveness of intervention tools
critical for elimination programming. The next steps are to investigate how packages of inter-
ventions can be modified to mitigate the effects of resistance on existing interventions
[30,121–123], how resistance can be contained [32], and how resistance can be avoided, partic-
ularly for new drugs and insecticides [124,125].
Human immunity
A gradual decline in human immunity to malaria across the population is an inevitable conse-
quence of reducing malaria transmission and contracting parasite diversity [126,127]. The
resulting delay in acquiring immunity likely will alter the age distribution and severity of
malaria infections [126,128,129]. Understanding these changes is necessary to identify the
most vulnerable populations or those most likely to need an intervention [128,130]. Models
already include age-dependent immune factors and have dynamic modulation of immunity as
a function of entomological inoculation rate [128,131], though additional temporal data could
help reduce the uncertainty surrounding these functions. Gaps remain in our understanding
of immunity in areas of long-standing low transmission (e.g., Haiti), where the level of asymp-
tomatic infections is much higher than previously thought [132].
Modelling to inform policy
Strategic decisions are already being taken as part of elimination planning in a number of
countries. There are numerous opportunities for modelling to inform these decisions—for
example, scenario planning. An Elimination Scenario Planning (ESP) toolkit was published by
WHO in 2014 following field testing using data from The Gambia and Senegal [14]. The
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manual is linked to software that models malaria transmission (currently limited to P. falcipa-
rum in Africa), which allows users to explore the effect of a range of combinations of malaria
control interventions in order to achieve elimination. Such an approach has wide application
and could be extended to P. falciparum outside Africa or P. vivax settings in the future. A key
consideration is that malaria policy will need to respond to climate change. Historical data
may become less reliable as seasonal patterns of rainfall and land use alter. Mapping climate
change effects and possible scenarios following the varied consequences of climate change for
human and vector population distributions has been investigated at continental and national
levels, but incorporating this into policy is more challenging [133–151].
Mathematical models can provide a framework for exploring the relationship between pop-
ulation movement, heterogeneous transmission, and the deployment logistics of a national or
regional elimination strategy. To carry out such analyses, new model frameworks should be
developed that benefit from new field and genetic data characterising and measuring spatially
and temporally dynamic transmission routes.
There is an increasing demand from NMCPs for pertinent and prompt mathematical
modelling analyses to support their malaria elimination strategies. Established modelling
groups have engaged in local capacity building. Also, malaria modelling research is being pub-
lished by research groups from malaria-endemic countries [33,34,62,89,152–154], and this
trend could be supported to the benefit of NMCPs.
Modelling to maintain zero
As noted above, when transmission becomes rare, models are increasingly challenged in
informing policy and intervention choices; similarly, when there is no transmission, the evalu-
ation of risk for the reintroduction of infection (vulnerability) and the risk of propagating local
transmission given its reintroduction (receptivity) can present challenges to models designed
to answer questions at high endemicity levels. A new class of highly heterogeneous, stochastic
malaria models is being developed to inform the design of an elimination surveillance system.
Vulnerability (risk of introduction or reintroduction). Measuring vulnerability to
malaria reintroduction requires pairing up-to-date maps of national and international parasite
prevalence with human movement models. Both of these fields have advanced in recent years
[33,34,117,155–160]. Human movement models, paired with travel survey and microcensus
data, have improved their description of routine human movement (e.g., holiday season travel)
[159,161]. Increasing use of mobile phones has enabled the tracking of human movement and
permitted distribution advice on infection avoidance [159,162–164]. However, many national
and international seasonal migrations remain difficult to predict, and their direct relationship
to moving malaria infections requires additional investigation.
Receptivity (risk of transmission given introduction). In order to direct interventions,
models must incorporate both the risk of importation and the risk for the reestablishment of
local transmission [165–173]. The risk of malaria transmission reestablishment can be mea-
sured as a function of selected host, vector, and environmental data [156,170,171, 174]. For
example, measures might include human use of insecticide-treated bed nets or indoor residual
spraying, mosquito habitat suitability and its link to abundance, and climatic conditions (e.g.,
temperature, rainfall, and vegetation index measures) that support or accelerate vector and
parasite development. If such data are collected widely enough, models can be validated using
the occasional areas that do experience local transmission. Deciding which environmental and
entomological data would be most valuable to collect could be iteratively informed by testing
hypotheses based on longitudinal data from areas that have recently eliminated malaria, for
example, Sri Lanka. The next step is to translate risk mapping into programmatic actions, such
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as better allocation of human resources, and maintenance and targeting of vector control
[50,175]. This will become increasingly important as more countries reach elimination.
Challenges
Residual transmission
Variable human and vector behaviours may enable sustained transmission in highly seasonal,
heterogeneous environments, despite high intervention coverage [176]. The magnitude and
importance of residual transmission in different settings require further field studies. In partic-
ular, human sociobehavioural data including human behaviour’s relevance for compliance
and entomological data investigating the contribution of outdoor transmission are needed to
develop models testing novel strategies and tools [102].
Low transmission and incorporating heterogeneity
Models have mostly been used to examine sub-Saharan Africa high transmission contexts with
P. falciparum and relevant vector species, though they may be parameterised across the full
spectrum of transmission. When modelling an isolated homogeneous population, it can be dif-
ficult to sustain transmission much below the 1% parasite prevalence level (though the precise
level depends on the model), with the model becoming unstable, leading to ‘stochastic extinc-
tion’, i.e., the extinction of parasites based on random effects within the model, an effect that is
compounded with increasing heterogeneity [177]. This suggests that importation of infections
and local heterogeneities in host, vector, and parasite dynamics and in health service delivery
systems are likely to play an important role in sustaining malaria in low transmission settings
[178].
As a country progresses to very low levels of malaria transmission, the spatial and temporal
heterogeneity of transmission increases in importance. In these contexts of varying historical
transmission intensity, intervention coverage, human movement, and access to health system
resources, malaria will tend to persist in the most remote regions and the poorest and most
vulnerable populations [179,180]. While this issue may not require new models per se, hetero-
geneity will need to be better captured as transmission declines. Spatial heterogeneity is proba-
bly least well developed, and the required level of spatial granularity and relevant metrics for
answering specific questions in low transmission settings requires definition [181,182]. How-
ever, at some point heterogeneity will exceed the ability of models to establish granularity, and
decision making will require local health system and entomological data.
Modelling malaria at borders
When malaria transmission is moderate to high and similar on both sides of a border, often lit-
tle attention is paid to border areas for specific disease interventions; however, this changes
when one nation may be markedly reducing transmission and the other is not. Border areas
present particular difficulties for malaria control and elimination efforts [183–187]. The com-
plexity of human movements for trade, business, and visiting family, sometimes including vul-
nerable populations [188], and the coordination of efforts between different political and
organisational frameworks increase the complexity of malaria control [184]. Some of the issues
relate to spatial and temporal heterogeneity and could possibly be addressed with greater data
on human cross-border movement and parasite genetics [189–191]. However, human factors,
such as local conflicts, poverty, and the disenfranchisement of particular ethnic groups, can be
highly variable in time and place and are more challenging to incorporate into transmission
models [192,193]. Alternative complementary approaches include mapping malaria risk, for
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better targeting of resources, plus goal setting by modelling what could potentially be achieved
with coordinated versus independent elimination campaigns [33,185,194,195]. Once the
potential benefits are understood, the barriers to reaching these goals can be researched and
the feasibility of overcoming them explored.
Iteration and validation
Finally, models directed at assessing combination interventions must embrace a process of
iteration with field data. In particular, data are needed from low to near-zero transmission set-
tings. Such data needs might include high-resolution geographic information on cases, fre-
quency and location of associated secondary cases, travel history identifying infection sources,
vector-associated data, climate, and environmental parameters [109]. The requirement for
field data to validate models remains problematic, as field data on intervention efficacy and the
diverse parameters noted above can be difficult to assemble. When developing models, valida-
tion requirements should be clearly defined and data should be feasible to obtain. Amidst
these challenges, modellers then need to consider how to best contribute to and bear responsi-
bility for the assembly of required field data. Although capacity building and integration of
modellers into NMCPs may address this at a local scale, there is a need for innovative mecha-
nisms to allow increased exchanges in malaria elimination research, to allow better access to
field empirical data for modellers.
Conclusions
Given the ongoing social and economic impact of malaria-related mortality and morbidity
and the inevitable resource constraints for national malaria programmes, identifying the most
timely and most cost-effective path to malaria elimination is a priority. Box 3 presents a
research and development agenda for combination interventions and modelling in malaria
elimination. Modelling affords a feasible and practical means of investigating rational combi-
nations of interventions and the most appropriate setting for their deployment. Nevertheless,
without a substantive dataset from operations research, the construction of meaningful models
Box 3. Research and development agenda for combination
interventions and modelling.
• Determine which combinations of interventions to use in which sequence and in
response to which triggers throughout elimination
• Identify the circumstances in which time-limited elimination acceleration interven-
tions, such as mass drug administration (MDA), are appropriate and what needs to be
done to retain the gains in transmission reduction following their withdrawal
• Model the effect of parasite drug and vector insecticide resistance on combination
interventions and how resistance might be avoided or contained
• Understand human immunity in areas where transmission has always been low and
parasite diversity very low and modelling the effect of changes in human immunity as
transmission declines
• Identify which additional data would be most useful for validating or changing model
predictions in order to drive iterative development and decision making
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is not possible. Models must also be continuously validated against field data, through pro-
grammatic experience and against clinical trials, with measures and outcomes data relevant to
the transmission setting identified and collected for use in further model refinement. This is
Surveillance as an intervention
• Model the target product profile of an elimination-specific surveillance system
• Determine the threshold at which reactive case strategies become feasible
Strategic modelling
• Estimate the long-term costs of elimination in different settings and with different
intervention packages
• Assess the potential duration of an elimination campaign in various settings to help
define the investment case and financing needs for elimination
• Estimate the maximal impact of currently available tools on elimination in various
settings
• Determine the counterfactual to elimination, i.e., the effect of continuing current
interventions in various settings
• Support capacity building of modellers embedded in National Malaria Control Pro-
grammes (NMCPs)
Modelling to maintain zero
• Investigate how vulnerability and receptivity measures can be translated into specific
programme actions
Addressing transmission
• Apply models to low transmission settings, incorporating all relevant parasites/vectors
• Investigate the importance of residual transmission in different settings and what new
strategies or novel tools are needed to overcome it
Incorporating heterogeneity
• Determine the relevance of spatial and temporal heterogeneity in transmission in dif-
ferent settings
• Investigate how much heterogeneity in transmission needs to be captured by models
to make predictions in elimination settings
Iteration and validation
• Determine which measures of transmission or other metrics are most appropriate for
guiding programmatic decisions in low transmission to maintaining-zero settings
• Define which new data need to be collected from low transmission to maintaining-
zero settings in order to increase confidence in model predictions
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especially the case as we increasingly encounter transmission settings that are shrinking in size
and number and becoming more focal and heterogeneous and for which there are fewer field
data. Thus, there is a codependency between modelling and field data, and the quality of both
must be assured for findings to be valid and impactful. Since malERA 2011, there has been sig-
nificant progress in aligning modelling with programmatic requirements and more effective
communication with policy makers. This ongoing dialogue will ultimately determine the rele-
vance of modelling to policy decision and its contribution towards achieving and maintaining
malaria elimination.
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